Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis

NCT06060886 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

244

Enrollment

OTHER_GOV

Sponsor class

Conditions

Schizophrenia
Treatment-resistant Schizophrenia
Side Effect
Lipid Metabolism Disorders
Diabetes
NAFLD
Psychosis

Interventions

DRUG: Aripiprazole
DRUG: Paliperidone

Sponsor

Consorcio Centro de Investigación Biomédica en Red (CIBER)

Collaborators

[object Object]